Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test
暂无分享,去创建一个
[1] J. Chander,et al. Phenotypic method for differentiation of carbapenemases in Enterobacteriaceae: study from north India. , 2012, Indian journal of pathology & microbiology.
[2] S. Kumari,et al. Burden of different beta-lactamase classes among clinical isolates of AmpC-producing Pseudomonas aeruginosa in burn patients: A prospective study , 2012, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.
[3] Thierry Naas,et al. Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.
[4] N. Goel,et al. Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India. , 2010, The Journal of the Association of Physicians of India.
[5] A. De,et al. Prevalence of metallo-β-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital , 2010, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.
[6] S. Pournaras,et al. A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. , 2010, The Journal of antimicrobial chemotherapy.
[7] Kenneth S. Thomson,et al. Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase Issues , 2010, Journal of Clinical Microbiology.
[8] V. Miriagou,et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[9] Yehuda Carmeli,et al. Carbapenem-resistant Enterobacteriaceae: a potential threat. , 2008, JAMA.
[10] A. Varaiya,et al. Incidence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in diabetes and cancer patients. , 2008, Indian journal of pathology & microbiology.
[11] J. Patel,et al. Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae , 2007, Journal of Clinical Microbiology.
[12] K. Bush,et al. Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.
[13] K. Bush,et al. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein , 1997, Antimicrobial agents and chemotherapy.
[14] in chief George M. Garrity. Bergey’s Manual® of Systematic Bacteriology , 1989, Springer New York.
[15] M. T. Parker,et al. Tests for the rapid breakdown of arginine by bacteria: their use in the identification of pseudomonads. , 1959, Journal of general microbiology.
[16] U. Pennsylvania,et al. Clinical and Laboratory Standards Institute , 2019, Springer Reference Medizin.
[17] P. Wayne. CLINICAL AND LABORATORY STANDARDS INSTITUTE. PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING , 2011 .
[18] G. Eliopoulos,et al. The carbapenems: new broad spectrum β-lactam antibiotics , 1989 .